Clinical Trial Update: Autologous Cord Blood Cells for Brain Injury in Term Newborns [Phase 1]

View source ↗

Summary

Phase 1 study evaluating autologous cord blood cell therapy for brain injury in term newborns with hypoxic ischemic encephalopathy. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Autologous cord blood cells

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Hypoxic Ischemic Encephalopathy | Phase 1 | Status: COMPLETED